Celiac Sprue Association/USA Inc. Registered Trade Mark

MEDLINEplus Health Information

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.

 

Web site design and hosting by
Aurora E-Solutions

This is the international recognized symbol for ‘gluten-free.’ At this time, however, there is not a single definition of ‘gluten-free’ that is accepted world-wide.

Celiac Sprue Association USA, Inc.
 
Celiacs Helping Celiacs

February 2005 Published Research

CSA has compiled informational synopses of

published research concerning CD, DH and related conditions.

To find more in-depth information on a particular research project, visit www.pubmed.gov.

 
Authors
Content
Publication Information
Alaedini A, Green PH. Narrative review: celiac disease: understanding a complex autoimmune disorder. Ann Intern Med. 2005 Feb 15;142(4):289-98. Review.
Bai D, Brar P, Holleran S, Ramakrishnan R, Green PH. Effect of gender on the manifestations of celiac disease: evidence for greater malabsorption in men. Scand J Gastroenterol. 2005 Feb;40(2):183-7.
Bonamico M, Sabbatella L, Di Tola M, Vetrano S, Ferri M, Nenna R, Mariani P, Picarelli A. Antiendomysial antibody detection in biopsy culture allows avoidance of gluten challenge in celiac children. J Pediatr Gastroenterol Nutr. 2005 Feb;40(2):165-9; discussion 122-4.
Bonamico M. Which is the best screening test for celiac disease in Down syndrome children? J Pediatr Gastroenterol Nutr. 2005 Feb;40(2):125-7. No abstract available.
Bouguerra R, Ben Salem L, Chaabouni H, Laadhar L, Essais O, Zitouni M, Haouet S, Ben Slama C, Ben Ammar A, Zouari B, Makni S. Celiac disease in adult patients with type 1 diabetes mellitus in Tunisia. Diabetes Metab. 2005 Feb;31(1):83-6.
Boynes SG, Moore PA, Shepherd CJ, Bennett CR. Anesthetic management of a patient with celiac disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 Feb;99(2):E8-E10.
Buchman AL. Population-based screening for celiac disease: improvement in morbidity and mortality from osteoporosis? Arch Intern Med. 2005 Feb 28;165(4):370-2. No abstract available.
Capparelli R, Ventimiglia I, Longobardo L, Iannelli D. Quantification of gliadin levels to the picogram level by flow cytometry. Cytometry A. 2005 Feb;63(2):108-13.
Chedid AD, Kruel CR, Chedid MF, Torresini RJ, Geyer GR. Development of clinical celiac disease after pancreatoduodenectomy: a potential complication of major upper abdominal surgery. Langenbecks Arch Surg. 2005 Feb;390(1):39-41. Epub 2004 Sep 24.
Dahlbom I, Olsson M, Forooz NK, Sjoholm AG, Truedsson L, Hansson T. Immunoglobulin G (IgG) anti-tissue transglutaminase antibodies used as markers for IgA-deficient celiac disease patients. Clin Diagn Lab Immunol. 2005 Feb;12(2):254-8.
Davie MW, Gaywood I, George E, Jones PW, Masud T, Price T, Summers GD. Excess non-spine fractures in women over 50 years with celiac disease: A cross-sectional, questionnaire-based study. Osteoporos Int. 2005 Feb 4; [Epub ahead of print]
Hansson T, Dahlbom I, Rogberg S, Nyberg BI, Dahlstrom J, Anneren G, Klareskog L, Dannaeus A. Antitissue transglutaminase and antithyroid autoantibodies in children with Down syndrome and celiac disease. J Pediatr Gastroenterol Nutr. 2005 Feb;40(2):170-4; discussion 125-7.
Keuchel M, Hagenmuller F. Small bowel endoscopy. Endoscopy. 2005 Feb;37(2):122-32.
Kleopa KA, Kyriacou K, Zamba-PapanicolaouE, Kyriakides T. Reversible inflammatory and vacuolar myopathy with vitamin E deficiency in celiac disease. Muscle Nerve. 2005 Feb;31(2):260-5.
Kozanoglu E, Basaran S, Goncu MK. Proximal myopathy as an unusual presenting feature of celiac disease. Clin Rheumatol. 2005 Feb;24(1):76-8. Epub 2004 Sep 2.
Lee ES, Pulido JS. Nonischemic central retinal vein occlusion associated with celiac disease. Mayo Clin Proc. 2005 Feb;80(2):157. No abstract available.
Lomb Z, Bajor J, Garamszegi M, Grexa E, Bogner B, Tovari L, Bero T. [Pneumatosis cystoides intestinalis, as a rare complications of celiac disease] Orv Hetil. 2005 Feb 20;146(8):369-74. Hungarian.
Lustenberger RW. [A 23-year old patient with chronic diarrhea. Celiac disease and lactose intolerance] Schweiz Rundsch Med Prax. 2005 Feb 2;94(5):163-4. German. No abstract available.
Maier KP. [The patient with slightly increased liver function tests] Schweiz Rundsch Med Prax. 2005 Feb 2;94(5):139-43. Review. German.
Molberg O, Uhlen AK, Jensen T, Flaete NS, Fleckenstein B, Arentz-Hansen H, Raki M, Lundin KE, Sollid LM. Mapping of gluten T-cell epitopes in the bread wheat ancestors: implications for celiac disease. Gastroenterology. 2005 Feb;128(2):393-401.
Qiao SW, Piper J, Haraldsen G, Oynebraten I, Fleckenstein B, Molberg O, Khosla C, Sollid LM. Tissue transglutaminase-mediated formation and cleavage of histamine-gliadin complexes: biological effects and implications for celiac disease. J Immunol. 2005 Feb 1;174(3):1657-63.
Schilling J, Spiekerkoetter U, Wohlrab U, Wendel U, Seissler J. Immunoglobulin isotype profile of tissue transglutaminase autoantibodies is correlated with the clinical presentation of coeliac disease. Scand J Immunol. 2005 Feb;61(2):207-12.
Shan L, Mathews II, Khosla C. Structural and mechanistic analysis of two prolyl endopeptidases: role of interdomain dynamics in catalysis and specificity. Proc Natl Acad Sci U S A. 2005 Mar 8;102(10):3599-604. Epub 2005 Feb
Stenson WF, Newberry R, Lorenz R, Baldus C, Civitelli R. Increased prevalence of celiac disease and need for routine screening among patients with osteoporosis. Arch Intern Med. 2005 Feb 28;165(4):393-9.
Stepniak D, Vader LW, Kooy Y, van Veelen PA, Moustakas A, Papandreou NA, Eliopoulos E, Drijfhout JW, Papadopoulos GK, Koning F. T-cell recognition of HLA-DQ2-bound gluten peptides can be influenced by an N-terminal proline at p-1. Immunogenetics. 2005 Apr;57(1-2):8-15. Epub 2005 Feb 16.
Thompson T. National Institutes of Health consensus statement on celiac disease. J Am Diet Assoc. 2005 Feb;105(2):194-5. Review. No abstract available.
Tiriveedhi K, Kelleher SP. Celiac sprue presenting as advanced liver disease. South Med J. 2005 Feb;98(2):245-7.
 
 


PO Box 31700 Omaha, NE 68131-0700
Toll Free: 877-CSA-4CSA · Fax: 402-558-1347 · Email: celiacs@csaceliacs.org